A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults
Clinical trial NCT04148118 · COMPLETED
Trial details
- NCT number
- NCT04148118
- Sponsor
- BlueWillow Biologics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-08
- Primary completion
- 2021-09-02
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.